Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind placebo-controlled study of CF04 ophthalmic solution in moderate to severe dry eye disease
CTR20242210Phase 2Active
- Sponsor
- Puyou Biotech
- Start
- Aug 2024
- Countries
- 1
01
Overview
A Phase 2 trial of CF04 in dry eye syndrome (DED), sponsored by Puyou Biotech. Started Aug 2024; status: active.
02
Drugs
CF04
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on CTR20242210.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20242210.